1007-3418
2009 Issue 4
Progress in diagnosis and treatment of liver cirrhosis
CHEN Jing;JIA Ji-dong
CHEN Jing;JIA Ji-dong
..............page:241-243
The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension
FANG Dian-chun;CHEN Lei
FANG Dian-chun;CHEN Lei
..............page:244-246
Long-term decreased portal pressure in cirrhotic patients with portal hypertension: reality or dream?
DING Hui-guo
DING Hui-guo
..............page:246-248
Bone marrow stem cells for treatment of liver cirrhosis
HAN Ying;WU Kai-chun;FAN Dai-ming
HAN Ying;WU Kai-chun;FAN Dai-ming
..............page:249-251
Therapeutic and prevention strategies of gastroesophageal varices and variceal hemorrhage in cirrhosis
XU Xiao-yuan;LI Lu
XU Xiao-yuan;LI Lu
..............page:252-253
Portal hypertensive gastropathy
TAO Xiao-hong
TAO Xiao-hong
..............page:254-256
Diagnosis and treatment of hepatopulmonary syndrome
ZHANG Da-zhi
ZHANG Da-zhi
..............page:256-257
..............page:插1
13C breath tests: a useful tool to quantify hepatic reserve function
QU Xin-hua;HUANG Xiao-lu;CAI Ming-ci;CHEN Zhi-wei;LU Lun-gen;YAN Wei-li;HUANG Gang
QU Xin-hua;HUANG Xiao-lu;CAI Ming-ci;CHEN Zhi-wei;LU Lun-gen;YAN Wei-li;HUANG Gang
..............page:318-320
..............page:317
A case report of severe hepatitis patient complicated with hemo-disseminated lung aspergillosis
CHEN Li;HE Zhi-yi;HE Shan-ming;ZHANG Ling;HUANG Bin;TU Yuan-yun;ZHANG Hong-xing;JIANG Yang-kun;LI Yi-zhong
CHEN Li;HE Zhi-yi;HE Shan-ming;ZHANG Ling;HUANG Bin;TU Yuan-yun;ZHANG Hong-xing;JIANG Yang-kun;LI Yi-zhong
..............page:315-316
The effect of thalidomine-induced NF-kappa B activation on malignant transformation of hepatocytes
YAO Deng-fu;YU Hong-bo;SHEN Jun-jun;WANG Yi-lang;WU Xin-hua;QIU Li-wei;WU Wei
YAO Deng-fu;YU Hong-bo;SHEN Jun-jun;WANG Yi-lang;WU Xin-hua;QIU Li-wei;WU Wei
..............page:312-314
Establishment of human hepatocellular carcinoma cell line expressing HBx shRNA
HE Xing-e;SUN Hui-qin;YANG Xu;LEI Jian-hua;TONG Ming;WANG Wen-long
HE Xing-e;SUN Hui-qin;YANG Xu;LEI Jian-hua;TONG Ming;WANG Wen-long
..............page:310-312
Effect of YC-1 on HIF-1 α and VEGF expression in human hepatocarcinoma cell lines
WANG Shun-xiang;PEI Zhi-zhong;WU Xiao-hui;LI Jian-kun;YANG Yong-jiang
WANG Shun-xiang;PEI Zhi-zhong;WU Xiao-hui;LI Jian-kun;YANG Yong-jiang
..............page:308-309
Study on the relation between hemodynamics of portal system and cirrhosis portal hypertension
LU Hai-ying;TIAN Xiu-lan;ZHANG Chen-xia;XU Xiao-yuan
LU Hai-ying;TIAN Xiu-lan;ZHANG Chen-xia;XU Xiao-yuan
..............page:306-307
The immunization effects of HBV core antigen and surface antigen fusion protein in mice
LI Lei;TIAN Yong-jun;SHEN Hong;ZHAO Xi-ping;YANG Dong-liang
LI Lei;TIAN Yong-jun;SHEN Hong;ZHAO Xi-ping;YANG Dong-liang
..............page:275-279
Analysis of spontaneous decline of HBV DNA in chronic hepatitis B patients in 12 weeks
HE Hua;XU Zhong-nan;CAI Da-chuan;NAI Ning;LING Ning;ZENG Wei-qun;SHI Xiao-feng;ZHAO You-rong;ZHOU Zhi;ZHANG Da-zhi
HE Hua;XU Zhong-nan;CAI Da-chuan;NAI Ning;LING Ning;ZENG Wei-qun;SHI Xiao-feng;ZHAO You-rong;ZHOU Zhi;ZHANG Da-zhi
..............page:271-274
S gene mutations in HBsAg/HBsAb double positive chronic hepatitis B patients
ZHANG Zhen-hua;PENG Jing;XIA Jian-bo;TIAN Yong-jun;JIANG Min;YANG Dong-liang
ZHANG Zhen-hua;PENG Jing;XIA Jian-bo;TIAN Yong-jun;JIANG Min;YANG Dong-liang
..............page:266-270
The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis
ZHANG Jun-yong;KUAI Jing-hua;JIA Ji-dong;WANG Bao-en;QIN Cheng-yong
ZHANG Jun-yong;KUAI Jing-hua;JIA Ji-dong;WANG Bao-en;QIN Cheng-yong
..............page:263-265
Ischemic hepatitis in hepatitis B related liver cirrhotic patients with upper gastrointestinal hemorrhage:clinical features and prognostic implications
FAN Chun-lei;DUAN Jin;DONG Pei-ling;OU-YANG Ying;ZHANG Bin;PING Chun-xia;DING Hui-guo
FAN Chun-lei;DUAN Jin;DONG Pei-ling;OU-YANG Ying;ZHANG Bin;PING Chun-xia;DING Hui-guo
..............page:258-262
Effect of tea polyphenols on expression of nuclear factor kappa B
TANG Yuan-ting;GUAN Xiao-qin;LIU Li;LIU Lin;WANG Li-juan
TANG Yuan-ting;GUAN Xiao-qin;LIU Li;LIU Lin;WANG Li-juan
..............page:301-305
Induction of SMYD3 by hepatitis B virus X gene in HepG2 cells
YANG Lian;REN Jian;HE Jun;CHEN Li-bo
YANG Lian;REN Jian;HE Jun;CHEN Li-bo
..............page:297-300
The effect of hepatitis B virus X protein on the c-met promoter activity in HepG2 cells
XIE Bin;TANG Chun;CHEN Ping;GOU Yuan-bin;XIAO Jing;DU Hu
XIE Bin;TANG Chun;CHEN Ping;GOU Yuan-bin;XIAO Jing;DU Hu
..............page:292-296
Correlaion between serum Golph2 protein and hepatocellular carcinoma
TAN Long-yi;CHEN Jie;WANG Hao;YE Han-qing;LI Qian;Gu Ji-an;HAN Li-qin
TAN Long-yi;CHEN Jie;WANG Hao;YE Han-qing;LI Qian;Gu Ji-an;HAN Li-qin
..............page:288-291
Role of focal adhesion kinase in the hypoxia-induced invasion of SMMC-7721 cells
YAN Wei;TIAN De-an;FU Yu;LIAO Jia-zhi;XIA Li-min;LUO Min;ZHU Qian
YAN Wei;TIAN De-an;FU Yu;LIAO Jia-zhi;XIA Li-min;LUO Min;ZHU Qian
..............page:284-287
Two-dimensional electrophoresis analysis of hydrophobic membrane proteome in mouse hepatocarcinoma cell H22
LIU Qiu-jun;LI Hong;YAN Dong-mei;LIU You-ping;YANG Ye
LIU Qiu-jun;LI Hong;YAN Dong-mei;LIU You-ping;YANG Ye
..............page:280-283